跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
艾乐妥 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Apixaban Tablets
Approved
化学药品
Apixaban Tablets
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD
🇨🇳 National Medical Products Administration
Approval Date
Sep 28, 2022
Approval ID
efd3d678b4045863
Company
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD
Type
化学药品
Approval Details
Approval Id
efd3d678b4045863
Approval Number
国药准字HJ20170237
Generic Name
阿哌沙班片
Generic Name En
Apixaban Tablets
Trade Name
艾乐妥
Drug Type
化学药品
Dosage Form
片剂
Strength
2.5mg
Reg Date
2022-09-28
Expired Date
2027-09-26
Company Name
BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD
Company Detail Path
/organization/bristol-myers-squibb-australia-pty-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 28, 2022
Approval ID
efd3d678b4045863
Type
化学药品
Back to NMPA Approvals